Community news|31/10/18

New fact sheets on nanomaterials and practical tools for managing dangerous substances

Home > The news of EUROGIP and occupational risks in Europe > New fact sheets on nanomaterials and practical tools for managing dangerous substances

EU-OSHA has created two new fact sheets related to the campaign on “Healthy Workplaces – Controlling the use of dangerous substances”:

Practical tools and guidance on dangerous substances in workplaces: presented in a database, to ensure efficient safety and health management;
Manufactured nanomaterials in the workplace.

Visit the Healthy Workplaces Manage Dangerous Substances website.

Discover other news

Discover all our news

Standardization

02/06/23

Standardisation to improve baggage handling conditions at airports

Getting luggage to the aircraft holds always requires the intervention of a handler at one time or another. Standardisation has played an important role in safeguarding the health of baggage handlers, but it is complex to implement.

Learn more

Community news

02/06/23

AI: MEPs approve new transparency and risk management rules

On 11 May, MEPs on the Internal Market and Civil Liberties Committees adopted a joint draft negotiating mandate for the world's first rules on artificial intelligence (AI).

Learn more

Community news

02/06/23

The state of occupational health and safety in Europe and trends in 2023

On the occasion of the 2023 summit on health and safety at work (OSH) organised in mid-May by the Swedish Presidency and the European Commission, EU-OSHA presented its flagship report “Safety and health at work in Europe: status and trends in 2023”.

Learn more

News

02/06/23

New EUROGIP study on the recognition of work-related mental disorders in Europe

It is now accepted that working conditions can have an impact on workers' mental health. The prevention of psychosocial risks has therefore become a priority in many countries. But the question of recognising psychological diseases as work-related is far from being unanimously accepted in Europe. EUROGIP devoted its latest study to this issue.

Learn more

Discover all our news